Evidence map›Paper›PMID 41212247›Full record

Observational studyWorld journal of urology2025

How does RIRS impact on stent-related symptoms? Insights from a prospective observational study by EAU-YAU endourology and urolithiasis working group.

Arman Tsaturyan, Etienne Xavier Keller, Stefano Mancon, Hayk Grigoryan, Tarik Emre Sener, Eugenio Ventimiglia, Francesco Esperto, Vincent De Coninck, Patrick Juliebø-Jones, Begona Ballesta Martinez and 11 more

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in World journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Arman TsaturyanDepartment of Urology, Yerevan State Medical University, Yerevan, Armenia. tsaturyanarman@yahoo.com.
Etienne Xavier KellerEAU Young Academic Urologists (YAU) Urolithiasis and Endourology Working Group Arnhem, NL-6803, Arnhem, The Netherlands.
Stefano ManconDepartment of Urology, Humanitas Clinical and Research Institute IRCCS, Rozzano, Milan, Italy.
Hayk GrigoryanDepartment of Urology, Yerevan State Medical University, Yerevan, Armenia.
Tarik Emre SenerEAU Young Academic Urologists (YAU) Urolithiasis and Endourology Working Group Arnhem, NL-6803, Arnhem, The Netherlands.
Eugenio VentimigliaEAU Young Academic Urologists (YAU) Urolithiasis and Endourology Working Group Arnhem, NL-6803, Arnhem, The Netherlands.
Francesco EspertoEAU Young Academic Urologists (YAU) Urolithiasis and Endourology Working Group Arnhem, NL-6803, Arnhem, The Netherlands.
Vincent De ConinckEAU Young Academic Urologists (YAU) Urolithiasis and Endourology Working Group Arnhem, NL-6803, Arnhem, The Netherlands.
Patrick Juliebø-JonesEAU Young Academic Urologists (YAU) Urolithiasis and Endourology Working Group Arnhem, NL-6803, Arnhem, The Netherlands.
Begona Ballesta MartinezEAU Young Academic Urologists (YAU) Urolithiasis and Endourology Working Group Arnhem, NL-6803, Arnhem, The Netherlands.
Ioannis MykoniatisEAU Young Academic Urologists (YAU) Urolithiasis and Endourology Working Group Arnhem, NL-6803, Arnhem, The Netherlands.
Alba Sierra Del RioEAU Young Academic Urologists (YAU) Urolithiasis and Endourology Working Group Arnhem, NL-6803, Arnhem, The Netherlands.
Lazaros TzelvesEAU Young Academic Urologists (YAU) Urolithiasis and Endourology Working Group Arnhem, NL-6803, Arnhem, The Netherlands.
Alberto OliveroEAU Young Academic Urologists (YAU) Urolithiasis and Endourology Working Group Arnhem, NL-6803, Arnhem, The Netherlands.
Mariela CorralesEAU Young Academic Urologists (YAU) Urolithiasis and Endourology Working Group Arnhem, NL-6803, Arnhem, The Netherlands.
Victoria JahrreissEAU Young Academic Urologists (YAU) Urolithiasis and Endourology Working Group Arnhem, NL-6803, Arnhem, The Netherlands.
Ali TalyshinskiiEAU Young Academic Urologists (YAU) Urolithiasis and Endourology Working Group Arnhem, NL-6803, Arnhem, The Netherlands.
Matthias BoeykensEAU Young Academic Urologists (YAU) Urolithiasis and Endourology Working Group Arnhem, NL-6803, Arnhem, The Netherlands.
Rifat ErgulEAU Young Academic Urologists (YAU) Urolithiasis and Endourology Working Group Arnhem, NL-6803, Arnhem, The Netherlands.
Lukasz NowakEAU Young Academic Urologists (YAU) Urolithiasis and Endourology Working Group Arnhem, NL-6803, Arnhem, The Netherlands.
Amelia PietropaoloEAU Young Academic Urologists (YAU) Urolithiasis and Endourology Working Group Arnhem, NL-6803, Arnhem, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo assess the perception and severity of stent-related symptoms (SRS) in patients undergoing retrograde intrarenal surgery (RIRS). MATERIALS AND

methodsA prospective observational study was performed including patients with single or multiple renal stones undergoing ureteral stenting and scheduled for a definitive RIRS. SRS were evaluated at 3 timepoints: pre-operatively on the day of RIRS, as well as on the 1st and 7th postoperative day following RIRS. Bladder pain, back pain, hematuria, urgency, frequency, nocturia, and urge incontinence were evaluated using a visual analog scoring (VAS) system.

resultsA total of 57 patients were included. The patients reported a significant rise in back pain at day 1 after RIRS (mean rank 2.25 on a scale of 0 to 5) compared to preoperative scores (2.06), with a significant decrease at day 7 following RIRS (1.68) (p = 0.003). A similar pattern was observed for bladder pain, frequency and urge incontinence (all p < 0.001). As for urgency and nocturia, these SRS steadily decreased from baseline to day 1, and in turn from day 1 to day 7 after RIRS (p = 0.004 and p = 0.003, respectively). Hematuria was the only SRS which did not show any significant differences over the 3 evaluated timepoints.

conclusionRIRS temporarily increases certain SRS, particularly pain and urinary discomfort within the first 24 h postoperatively. These symptoms tend to improve by the 7th postoperative day, suggesting that surgery itself may contribute to the early symptom burden but ultimately facilitates recovery. Further multi-center prospective studies with bigger sample size are warranted to confirm our findings.

Indexed as

Kidney CalculiPostoperative ComplicationsStentsAdultAgedFemaleHematuriaHumansMaleMiddle AgedProspective StudiesLithotripsyRIRSStent-related symptomsUreteral stentingUreteroscopy

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.